Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lederman

Showing results (51-60 of 707) with videos related to

Pageof 71
Sort By:
Current Opinion in HIV and AIDS|April 3, 2009
Targeting a host element as a strategy to block HIV replication: is it nice to fool with Mother Nature?Michael M Lederman, Jose Este
Ageing Research Reviews|May 17, 2016
Ataxia-telangiectasia (A-T): An emerging dimension of premature ageingYosef Shiloh, Howard M Lederman
The Journal of Clinical Investigation|April 1, 1986
Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsM Katzman, M M Lederman
Journal of Medical Systems|April 21, 2005
Systems failure in hospitals--using Reason's model to predict problems in a prescribing information systemR M Lederman, C Parkes
JAMA|July 13, 2000
Immune restoration with antiretroviral therapies: implications for clinical managementM M Lederman, H Valdez
U.S. Healthcare|February 8, 1989
O.R.I.S. (operating room information system)--a solution whose time has comeM Lederman, J P Weil
Pathogens & Immunity|December 5, 2017
Ten Years HIV Free: An Interview with "The Berlin Patient," Timothy Ray BrownMichael M Lederman, Earl Pike
Seminars in Immunology|July 16, 2008
The lymph node in HIV pathogenesisMichael M Lederman, Leonid Margolis
AIDS Clinical Review|September 22, 2000
Rationale for immune-based therapies for human immunodeficiency virus type 1 infectionM M Lederman, H Valdez
AIDS Clinical Review|January 1, 1997
Cytokines and cytokine therapies in HIV infectionH Valdez, M M Lederman
Pageof 71

Showing results (51-60 of 707) with videos related to

Sort By:
Pageof 71
Current Opinion in HIV and AIDS|April 3, 2009
Targeting a host element as a strategy to block HIV replication: is it nice to fool with Mother Nature?Michael M Lederman, Jose Este
Ageing Research Reviews|May 17, 2016
Ataxia-telangiectasia (A-T): An emerging dimension of premature ageingYosef Shiloh, Howard M Lederman
The Journal of Clinical Investigation|April 1, 1986
Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsM Katzman, M M Lederman
Journal of Medical Systems|April 21, 2005
Systems failure in hospitals--using Reason's model to predict problems in a prescribing information systemR M Lederman, C Parkes
JAMA|July 13, 2000
Immune restoration with antiretroviral therapies: implications for clinical managementM M Lederman, H Valdez
U.S. Healthcare|February 8, 1989
O.R.I.S. (operating room information system)--a solution whose time has comeM Lederman, J P Weil
Pathogens & Immunity|December 5, 2017
Ten Years HIV Free: An Interview with "The Berlin Patient," Timothy Ray BrownMichael M Lederman, Earl Pike
Seminars in Immunology|July 16, 2008
The lymph node in HIV pathogenesisMichael M Lederman, Leonid Margolis
AIDS Clinical Review|September 22, 2000
Rationale for immune-based therapies for human immunodeficiency virus type 1 infectionM M Lederman, H Valdez
AIDS Clinical Review|January 1, 1997
Cytokines and cytokine therapies in HIV infectionH Valdez, M M Lederman
Pageof 71